These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26248235)

  • 1. Is hormone therapy during climacteric for all?
    Soares Júnior JM; Sorpreso IC; Baracat EC
    Rev Assoc Med Bras (1992); 2015; 61(3):191-2. PubMed ID: 26248235
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hormones and alternative treatment possibilities in climacteric. What helps in hot flashes?].
    Hess C
    MMW Fortschr Med; 2008 May; 150(19):18-9. PubMed ID: 18589858
    [No Abstract]   [Full Text] [Related]  

  • 3. [What do you prescribe for climacteric symptoms? (interview by Friederike Klein)].
    Ortmann O
    MMW Fortschr Med; 2005 Nov; 147(47):21. PubMed ID: 16370190
    [No Abstract]   [Full Text] [Related]  

  • 4. [Only two secure indications left. Changing one's view of hormone replacement therapy].
    Fath R
    Dtsch Med Wochenschr; 2003 Oct; 128(43):2236. PubMed ID: 14608994
    [No Abstract]   [Full Text] [Related]  

  • 5. By the way, doctor... I don't know whether to start hormone-replacement therapy. I'm having a terrible time with hot flashes, but I'm worried about the risk for ovarian and breast cancer. What should I do?
    Lee TH
    Harv Health Lett; 2001 Jun; 26(8):8. PubMed ID: 11439435
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current debate on hormone replacement therapy].
    Georges B; Hermelink K; Untch M; Hepp H
    Gynakol Geburtshilfliche Rundsch; 2004 Apr; 44(2):63-8. PubMed ID: 15073435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oncologic indications and contra-indications for hormones use in menopause].
    Sarriá JA
    Rev Fac Cien Med Univ Nac Cordoba; 2005; 62(2 Suppl 1):59-66. PubMed ID: 16972744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer].
    Magnusson C; Weiderpass E
    Lakartidningen; 2001 Jan; 98(5):418-21. PubMed ID: 11229082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [After discontinuation of the Women's Health Initiative Study of hormone substitution. Should hormone replacement be stopped? (interview by Dr. Brigitte Moreano)].
    Seifert-Klauss V
    MMW Fortschr Med; 2002 Jul; 144(29-30):16. PubMed ID: 12219606
    [No Abstract]   [Full Text] [Related]  

  • 10. The thoughts of breast cancer survivors regarding the need for starting hormone replacement therapy.
    Trinh XB; Peeters F; Tjalma WA
    Eur J Obstet Gynecol Reprod Biol; 2006 Feb; 124(2):250-3. PubMed ID: 16144734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hormone replacement therapy in peri- and postmenopausal women and breast cancer risk].
    Buchholz S; Horn F; Ortmann O
    Ther Umsch; 2008 Apr; 65(4):231-4. PubMed ID: 18622916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Committee opinion: number 262, December 2001. Risk of breast cancer with estrogen-progestin replacement therapy.
    ACOG Committee on Gynelogical Practice
    Obstet Gynecol; 2001 Dec; 98(6):1181-4. PubMed ID: 11755583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Indications critically evaluated: hormone-domain hot flashes].
    MMW Fortschr Med; 2003 Nov; 145(46):5-8. PubMed ID: 14699822
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of the climacteric. Options abound to relieve women's midlife symptoms.
    Morrissey DR; Kirchner JT
    Postgrad Med; 2000 Jul; 108(1):85-8, 93-4, 97-100. PubMed ID: 10914121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hot flush: the enigma of the climacteric.
    Sturdee DW
    Climacteric; 2001 Mar; 4(1):1-3. PubMed ID: 11379372
    [No Abstract]   [Full Text] [Related]  

  • 16. [Increased risk of breast cancer following hormone replacement therapy during climacteric. 3 440 extra cases might have been caused by the treatment in Sweden during the 1990s].
    Magnusson C; Reeves G
    Lakartidningen; 2005 Apr 18-24; 102(16):1228-30. PubMed ID: 15921095
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hormone replacement therapy (HRT) in peri- and postmenopause. Is it also allowed after treatment of breast carcinoma?].
    Graf H; Retzke U
    Zentralbl Chir; 1998; 123 Suppl 5():151-5. PubMed ID: 10063602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hormone replacement therapy and the risk of developing breast cancer].
    Merz WE
    MMW Fortschr Med; 2004 Feb; 146(9):26-8, 30. PubMed ID: 15352702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hormone replacement therapy: curse or blessing?].
    Schmidt M; Fink D; Lang U; Kimmig R
    Gynakol Geburtshilfliche Rundsch; 2006; 46(4):165. PubMed ID: 17068400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy in postmenopausal women.
    Bush NJ; Griffin-Sobel JP
    Oncol Nurs Forum; 2003; 30(5):747-9. PubMed ID: 12966930
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.